Pharmacovigilance Market to Surge to USD 22.3 Billion by 2032 Driven by Rising Drug Safety Awareness

NEW YORK - Sept. 16, 2025 - PRLog -- Latest research report on the Pharmacovigilance Market reveals robust growth and transformative trends poised to reshape drug safety and monitoring across the globe. According to the report, the Pharmacovigilance Market Size was approximately USD 7.9 billion in 2022, and it is expected to expand to USD 22.3 billion by 2032, achieving an 11.2% CAGR from 2023 through 2032.

Pharmacovigilance Market Statistics

• Market Size (2022): USD 7.9 billion
• Forecast Market Size (2032): USD 22.3 billion
• CAGR (2023-2032): 11.2%
• North America (2022) Market Value: ~ USD 2.4 billion
• Asia-Pacific Region Growth Rate: Expected to exceed 12% CAGR

Pharmacovigilance Market Analysis & Growth Drivers

The Pharmacovigilance Market Growth is being driven by several critical factors:

• Increased R&D investments in pharmaceutical and biotech sectors demanding stronger post-approval safety surveillance.
• Rising number of adverse drug reactions (ADRs) and regulatory pressure emphasizing drug safety and compliance.
• Heightened public awareness about medication safety and transparency.
• Technological adoption including electronic health records, real-world data integration, and advancements in data authenticity and traceability.

Get Free PDF Report Sample: https://www.acumenresearchandconsulting.com/request-sample/1331

Pharmacovigilance Market Trends Shaping the Industry

• Deployment of Contract Research Organizations (CROs) and Business Process Outsourcing (BPO) firms to handle pharmacovigilance activities.
• Growing interest in real-world data mining and cohort event monitoring for more accurate safety profiles.
• Exploration of emerging technologies like blockchain to enhance data integrity, privacy, and security in safety monitoring systems.

Regional Insights & Market Share

• North America remains the leading region in terms of market share, with a strong regulatory framework and well-established pharmacovigilance infrastructure.
• Asia-Pacific is emerging as the fastest growing market, driven by increasing pharmaceutical manufacturing, rising patient safety awareness, and expanding access to healthcare.

Competitive Landscape

Key players in the Pharmacovigilance Market Share include major global firms known for offering advanced drug safety solutions, clinical trial services, and regulatory monitoring. These companies are focusing on expanding service offerings, improving compliance technologies, and forging alliances to strengthen market position.

Outlook & Future Opportunities

Pharmacovigilance Market Report forecasts steady momentum through 2032. Opportunities lie in expanding real-world evidence initiatives, deploying more automated systems for ADR reporting, and further integrating patient data systems. Key challenges to address include regulatory complexity, cost of compliance, maintaining data privacy, and the scarcity of skilled talent in pharmacovigilance.

Read Detailed Analysis at Globenewswire: https://www.globenewswire.com/news-release/2023/10/09/2756841/0/en/Pharmacovigilance-Market-Projected-to-Attain-USD-22-3-Billion-by-2032-Exhibiting-a-11-2-CAGR-from-2023-2032.html